[Drug-induced thrombotic thrombocytopenic purpura].
Takahashi
Ryuichi
R
National Tokyo Medical Center.
D018501:Antirheumatic Agents / Q000009:adverse effects; D001241:Aspirin / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D010396:Penicillamine / Q000009:adverse effects; D010949:Plasma; D010951:Plasma Exchange; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011379:Prognosis; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D013988:Ticlopidine / Q000009:adverse effects*
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors; D016572:Cyclosporine; D010396:Penicillamine; D013988:Ticlopidine; D001241:Aspirin